Stock Movers Moderna Falls, Synopsys Gains, Barrick Mining Rises on IPO News
6 snips
Dec 1, 2025 Norma Linden, a Bloomberg reporter with a keen eye on market movers, discusses the latest shifts in the stock landscape. She reveals how new FDA safety concerns caused vaccine stocks to dip. In exciting news, Nvidia’s $2 billion investment is propelling Synopsys shares upward. Linden also highlights Barrick Mining's potential IPO of North American gold assets, a move seen as positive by analysts, potentially attracting further attention from companies like Newmont.
AI Snips
Chapters
Transcript
Episode notes
Vaccine Stocks Fall On Safety Memo
- The FDA memo linked COVID-19 vaccines to myocarditis concerns in younger people, prompting a sector sell-off.
- Norma Linden reports vaccine makers like Moderna and Pfizer fell after the safety-related memo surfaced.
Nvidia's $2B Bet Boosts Synopsys
- Nvidia agreed to invest $2 billion in Synopsys as part of a strategic engineering and design partnership.
- Norma Linden says the deal lifted Synopsys shares nearly 7% and highlights massive capital flows into AI ecosystems.
Barrick Eyes IPO For North American Assets
- Barrick is exploring an IPO of its North American gold assets, which analysts view positively for shares.
- Norma Linden notes the move could make Barrick a potential acquisition target and pushed shares higher.